- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Remdesivir: A Review in COVID-19 ; volume:83 ; number:13 ; day:17 ; month:8 ; year:2023 ; pages:1215-1237 ; date:9.2023
Drugs ; 83, Heft 13 (17.8.2023), 1215-1237, 9.2023
- Urheber
-
Blair, Hannah A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40265-023-01926-0
- URN
-
urn:nbn:de:101:1-2023111411242030626228
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Blair, Hannah A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: Remdesivir: A Review in COVID-19
Remdesivir for the Treatment of COVID-19: A Narrative Review
Remdesivir (COVID-19) : Nutzenbewertung gemäß § 35a SGB V
Remdesivir: Critical Clinical Appraisal for COVID 19 Treatment
That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment
Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review
Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review
Outcomes Among Patients Hospitalized for COVID-19 Treated with Remdesivir in an Urban Center Pre-COVID-19 Vaccination
Hemoadsorption eliminates remdesivir from the circulation: Implications for the treatment of COVID‐19
The use of remdesivir outside of clinical trials during the COVID-19 pandemic
Correction to: Remdesivir: A Review in COVID-19
Remdesivir for the Treatment of COVID-19: A Narrative Review
Remdesivir (COVID-19) : Nutzenbewertung gemäß § 35a SGB V
Remdesivir: Critical Clinical Appraisal for COVID 19 Treatment
That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment
Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review
Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review
Outcomes Among Patients Hospitalized for COVID-19 Treated with Remdesivir in an Urban Center Pre-COVID-19 Vaccination
Hemoadsorption eliminates remdesivir from the circulation: Implications for the treatment of COVID‐19
The use of remdesivir outside of clinical trials during the COVID-19 pandemic
Correction to: Remdesivir: A Review in COVID-19
Remdesivir for the Treatment of COVID-19: A Narrative Review
Remdesivir (COVID-19) : Nutzenbewertung gemäß § 35a SGB V
Remdesivir: Critical Clinical Appraisal for COVID 19 Treatment
That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment
Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review
Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review
Outcomes Among Patients Hospitalized for COVID-19 Treated with Remdesivir in an Urban Center Pre-COVID-19 Vaccination
Hemoadsorption eliminates remdesivir from the circulation: Implications for the treatment of COVID‐19